Irofulven as first line therapy in recurrent or metastatic gastric cancer: a phase II multicenter study by the Cancer Therapeutics Research Group (CTRG)

Author： Yeo W.   Boyer M.   Chung H.   Ong S.   Lim R.   Zee Benny   Ma B.   Lam K.   Mo F.   Ng E.   Ho R.   Clarke S.   Roh J.   Beale P.   Rha S.   Jeung H.   Soo R.   Goh B.   Chan A.  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.59, Iss.3, 2007-03, pp. : 295-300

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer

By Chao Yee   Hsieh Jan-Sing   Yeh Hsien-Tang   Su Yu-Chieh   Wu Cheng-Chung   Chen Jen-Shi   Tai Cheng-Jeng   Bai Li-Yuan   Yeh Kun-Huei   Su Wu-Chou   Li Chung-Pin  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 4, 2014-04 ,pp. : 799-806

Springer Publishing Company

Access to resources Recommend Favorite

Raltitrexed plus weekly oxaliplatin as first-line chemotherapy in metastatic colorectal cancer: A multicenter non-randomized phase II study

By Santini Daniele   Massacesi Cristian   D’Angelillo Rolando   Marcucci Fabiana   Campisi Costantino   Vincenzi Bruno   Pilone Alberta   Bianco Vincenzo   Bonsignori Maurizio   Tonini Giuseppe  

Medical Oncology, Vol. 21, Iss. 1, 2004-03 ,pp. : 59-66

Humana Press, Inc

Access to resources Recommend Favorite

Capecitabine plus paclitaxel as front-line combination therapy for metastatic breast cancer: a multicenter phase II study

By  

The Women's Oncology Review, Vol. 4, Iss. 4, 2004-12 ,pp. : 283-285

Informa Healthcare

Access to resources Recommend Favorite

Phase II clinical study of irinotecan and cisplatin as first-line chemotherapy in metastatic or recurrent cervical cancer

By Chitapanarux I.   Tonusin A.   Sukthomya V.   Charuchinda C.   Pukanhapan N.   Lorvidhaya V.  

Gynecologic Oncology, Vol. 89, Iss. 3, 2003-06 ,pp. : 402-407

Elsevier

Access to resources Recommend Favorite

Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer

By Idelevich Efraim   Karminsky Natalie   Dinerman Michael   Katsenelson Rivka L.   Zvi Nana Ben   Baruch Noa Ben   Biran Haim   Man Sofia   Shani Adi  

Acta Oncologica, Vol. 46, Iss. 3, 2007-01 ,pp. : 324-329

Informa Healthcare

Access to resources Recommend Favorite